Searched over 200M research papers
10 papers analyzed
These studies suggest that while mortality rates in type 1 diabetes patients remain higher than those without diabetes, advances in care have led to improved long-term survival, though disparities exist based on gender, age, and ethnicity.
20 papers analyzed
Type 1 diabetes (T1D) significantly impacts mortality rates worldwide, with variations observed across different regions. The International Diabetes Federation (IDF) Diabetes Atlas reports that the prevalence of T1D in children and adolescents is increasing globally. However, higher mortality rates in less-developed countries have led to a decrease in prevalence estimates in regions like sub-Saharan Africa.
Historical data from the Allegheny County Registry in Pennsylvania, covering patients diagnosed between 1965 and 1979, revealed a crude mortality rate of 627 per 100,000 person-years. The study noted significant improvements in survival rates over time, attributed to advancements in diabetes management, such as HbA1 testing and home blood glucose monitoring. Similarly, a study from the Steno Diabetes Centre in Denmark observed a decline in mortality rates by 6.6% per year in men and 4.8% per year in women from 2002 to 2011, indicating better diabetes care over the decade.
In the UK, data from the General Practice Research Database (GPRD) between 1992 and 1999 showed that individuals with T1D had an annual mortality rate of 8.0 per 1,000 person-years, significantly higher than the 2.4 per 1,000 person-years observed in the non-diabetic population. The hazard ratio for mortality was 3.7 times higher in T1D patients, with cardiovascular disease being the leading cause of death.
A systematic review and meta-analysis highlighted that women with T1D have a 40% greater excess risk of all-cause mortality compared to men. The risk of fatal and nonfatal vascular events was also twice as high in women. This gender disparity underscores the need for targeted interventions to address the specific health challenges faced by women with T1D.
Ethnic disparities in mortality rates are also evident. African Americans with T1D have higher mortality rates compared to Caucasians. This difference is particularly pronounced in diabetes-related deaths, which include acute complications and chronic conditions like cardiovascular and renal diseases.
The primary causes of death in T1D patients vary with the duration of the disease. In the early years post-diagnosis, acute diabetes complications are the leading cause of death. As the disease progresses, chronic complications such as cardiovascular and renal diseases become more prevalent. In Norway, a study found that acute metabolic complications were the most common cause of death in patients under 30 years, while cardiovascular disease was the leading cause in older patients.
Recent studies have identified emerging trends in mortality causes, including drug misuse and violent deaths. In the UK, 16% of deaths in young T1D patients were related to drug misuse, highlighting a growing concern that warrants further investigation.
Despite advancements in diabetes care, individuals with type 1 diabetes continue to experience higher mortality rates compared to the general population. Improvements in diabetes management have led to better survival rates over time, but significant disparities remain based on gender, ethnicity, and region. Addressing these disparities and focusing on the prevention of both acute and chronic complications are crucial for reducing mortality rates in T1D patients.
Most relevant research papers on this topic